Australian vaccine producer receives US$22 million grant from US government for needle-free vaccine patch technology

Vaxxas, an Australian vaccine producer, has developed a vaccine technology that does not require refrigeration and can be administered needle-free via a patch to the skin. The technology, called high density micro-array patch (HD-MAP), seeks to improve the performance of pandemic vaccines, including those for COVID-19, as well as of vaccines for non-pandemic infectious diseases.

The US$22 million funding is provided by the US Department of Health and Human Services to advance clinical demonstration of the HD-MAP technology to fight against the threat of pandemics.

Originating from the University of Queensland, Vaxxas has previously received funding from the pharmaceutical industry and the Bill and Melinda Gates Foundation.

News article - Business Wire